Suzhou Lixin Pharmaceutical Co Ltd

CDMO

China

http://www.szlxpharm.com/

Is this your company? Claim this profile

Drug Substance

Excipients & Specialty Ingredients

Analytical & Bioanalytical Services

Clinical Trial Supply & Logistics

Contract Research Organization

Company Overview

About

Suzhou Lixin Pharmaceutical Co., Ltd. is a privately-owned Chinese GMP manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, established in 2000. The company produces APIs including semaglutide, sitagliptin phosphate, and indapamide, with multiple FDA-registered facilities that have been FDA-inspected.

Key Expertise

API and intermediate manufacturing, semaglutide, sitagliptin phosphate, small molecule API synthesis

Therapeutic Areas

Metabolic Disease

Cardiovascular

Quick Facts

HQ:China

Capabilities & Services

Core Capabilities

Small Molecule API
API Manufacturing
Process Development

Production Scales

Commercial Scale

Annual Capacity

Medium Clinical (100 - 1,000 kg/year)

Commercial (1,000 - 10,000 kg/year)

Markets Served

Asia

Manufacturing Facilities

1 site worldwide

Suzhou Lixin Pharmaceutical Co Ltd - China Facility

China

View on Map

Site Capabilities

3 capabilities

Formulation Development

Process Development

Scale-up

Certifications

FDA Registration

U.S. Food and Drug Administration

NMPA (China)

National Medical Products Administration

Request an Introduction

Please log in to contact this provider.